The aim of this study was to report the effect of laser phototherapy (LPT) on the treatment of burning mouth syndrome (BMS). This prospective clinical study reports on preliminary outcomes of twenty volunteers diagnosed with BMS who have undergone the conventional treatment prior to laser phototherapy. LPT consisted of weekly sessions of LPT (660 nm), for a period of 10 weeks. The laser protocol consisted of the following parameters: 40 mW, 10 J cm(2) and 0.4 J per point, irradiation time of 10 s. In all sessions, the burning intensity was evaluated with a 10 cm Visual Analogue Scale (VAS). The burning intensity evaluation by VAS was performed immediately before and after each LPT session. Nonparametric test of Wilcoxon was used for statistical analysis, considering a significance level of 5%. All volunteers reported reduced burning intensity in all sessions when compared to the previous one and reduction in VAS scores by up to 49% in the last clinical session when compared to the first session. When only the VAS baseline of the first session was compared with the consecutive sessions, there was a statistically significant reduction in VAS scores in almost all sessions. The LPT may be an alternative treatment for the relief of oral burning symptoms in patients with BMS.
Introduction: Medication-related osteonecrosis of the jaw (MRONJ) corresponds to an adverse effect of the use of drugs such as bisphosphonates and denosumab. This condition is often associated with pain, infection, purulent secretion, paraesthesia, tooth mobility and halitosis, decreasing the patient’s quality of life. The management of MRONJ tends to be conservative, through the guidance of oral hygiene, antibiotic therapy and mouthwashes. However, the use of antimicrobial photodynamic therapy (aPDT) has shown promise in the treatment of these injuries. The purpose of this article is to report a case of MRONJ treatment associated with aPDT. Case Report: A 75-year-old patient, with a history of breast cancer and use of intravenous Zoledronic Acid, presented with bilateral MRONJ lesions in tuberosity on the right and left sides. Treatment was conservatively instituted with the use of aPDT as an adjuvant. After 12 aPDT sessions, complete regression of the lesion was observed. However, after two weeks, the presence of a new lesion was noted, this time in the anterior region of the maxilla. The same protocol previously established was followed and after two aPDT sessions, the patient returned with complete lesion regression. Conclusion: The use of aPDT may represent an important adjuvant within a set of clinical protocols in the treatment of MRONJ.
Objetivo: Identificar a condição bucal dos pacientes admitidos em unidades de terapia intensiva. Metodologia: Trata-se de um estudo observacional retrospectivo utilizando dados secundários de prontuário de pacientes admitidos nas unidades de terapia intensiva de um hospital de beneficência de alta complexidade da cidade do Recife, atendidos pela equipe de Odontologia Hospitalar no período de março de 2019 a fevereiro de 2020. Resultados: A amostra envolveu um total de 1831 pacientes, com idade média de 67,63 anos, sendo 50,8% do sexo masculino. As doenças neurológicas (19,9%) e do aparelho respiratório (18,8%) foram as responsáveis pelos maiores índices de admissões. As principais alterações bucais evidenciadas foram: cálculo dental (27,2%), fratura dentária (17,1%), lesão/infecção (14,4%) e ressecamento labial/bucal (10%). Conclusão: Conclui-se que o cálculo dental foi a alteração bucal mais frequente nos pacientes avaliados, observado com maior número nos pacientes com doenças neurológicas e do aparelho respiratório. A presença de infecção/lesão na cavidade bucal foi diagnóstica em maior índice nos pacientes oncológicos.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.